Screener
Royalty Pharma RPRX Equity Method Income
Equity Method Income at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expense, net | 541,022 | 368,866 | 608,561 | 402,932 |
| Operating income | 133,119 | 209,799 | 696,156 | 743,980 |
| Other (income)/expense | ||||
| Equity in earnings of equity method investees | (4,077) | (2,693) | (25,835) | (9,136) |
| Interest expense | 93,617 | 68,668 | 187,339 | 133,929 |
| (Gains)/losses on equity securities | (69,156) | 30,553 | (48,990) | 76,431 |
| Losses on available for sale debt securities | 34,880 | 27,420 | 41,560 | 30,701 |
| Interest income | (5,127) | (8,327) | (11,356) | (19,617) |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Royalty Pharma's equity method income?
- Royalty Pharma (RPRX) reported equity method income of $4.08M in Q2 2026.
- How has Royalty Pharma's equity method income changed year-over-year?
- Royalty Pharma's equity method income increased by 51.4% year-over-year, from $2.69M to $4.08M.
- What is the long-term trend for Royalty Pharma's equity method income?
- Over 4 years (2021 to 2025), Royalty Pharma's equity method income has grown at a 10.5% compound annual growth rate (CAGR), from -$19.49M to $29.09M.
- What does equity method income mean?
- The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.
Ask your AI about Royalty Pharma's equity method income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude